SCHEMBL5670851

SCHEMBL5670851

NC(N)=NC(=O)/C=C/c1cccc(OCC(F)(F)F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC4 P56524 1/20 0.50
▸ MEF2D Q14814 1/20 0.50
▸ KDM4E B2RXH2 4/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ HTR2B P41595 1/20 0.45
▸ PKM P14618 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ ATM Q13315 1/20 0.44
▸ MAOB P27338 4/20 0.40
▸ MAOA P21397 2/20 0.40
▸ FURIN P09958 1/20 0.40
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ GRIN1 Q05586 1/20 0.38
▸ GRIN2B Q13224 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5432549 0.84 HTR2B (0.47) KDM4EALDH1A1SMN1; SMN2HTR2BPKM
SCHEMBL5424266 0.84 KDM4E (0.67) HDAC4MEF2DKDM4EALDH1A1SMN1; SMN2
SCHEMBL15121483 0.80 HTR2B (0.45) HDAC4KDM4EALDH1A1SMN1; SMN2HTR2B
SCHEMBL5670848 0.80 HDAC4 (0.60) HDAC4MEF2DKDM4EALDH1A1SMN1; SMN2
SCHEMBL5425068 0.79 MAOB (0.58) SMN1; SMN2CYP3A4HPGDCYP2C19MAOB
SCHEMBL5443386 0.79 P4HB (0.56) KDM4EHTR2BPKMMAOBMAOA
SCHEMBL5672084 0.79 HTR2B (0.47) HDAC4MEF2DKDM4EALDH1A1HTR2B
SCHEMBL5441731 0.74 NFE2L2 (0.52) KDM4EALDH1A1SMN1; SMN2HTR2BMAOB
SCHEMBL2536091 0.72 MAOA (0.57) HDAC4MEF2DALDH1A1CYP3A4HPGD
SCHEMBL16953003 0.72 CYP2C19 (0.46) HDAC4MEF2DKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1646371-A2 ANTIVIRAL COMPOUNDS AND METHODS Biotron Limited (AU) 2006-04-19 — — EP claimed
WO-2004112687-A2 ANTIVIRAL ACYLGUANIDINE COMPOUNDS AND METHODS BIOTRON LIMITED (AU) 2004-12-29 — — WO claimed
Send feedback